EPO published patent application EP3437690A1 as a granted patent (Kind A1) on March 25, 2026. The invention relates to adhesive preparation management methods and devices for healthcare applications, with IPC classifications indicating use in drug delivery systems (A61K 9/70), medical devices (A61M 35/00, A61M 37/00), and health informatics (G16H 20/10). The patent is designated for all major European contracting states including Germany, France, UK, Italy, Spain, and 35 others.

This is a patent grant notification with no compliance implications. Competitors in the pharmaceutical adhesive or medical device sectors should review the patent claims to assess freedom-to-operate for related products. Companies developing transdermal drug delivery systems or adhesive-based medical devices may need to consider licensing or design-around strategies.